Prednisone combined with dihydroartemisinin inhibits the excessive activation of skin keratinocytes in lupus erythematosus by targeting MAPK14. // Molecular and Cellular Probes. – URL: https://www.sciencedirect.com/science/article/pii/S089085082600023X?dgcid=rss_sd_all
Prednisone combined with dihydroartemisinin inhibits the excessive activation of skin keratinocytes in lupus erythematosus by targeting MAPK14. Molecular and Cellular Probes. https://www.sciencedirect.com/science/article/pii/S089085082600023X?dgcid=rss_sd_all
“Prednisone combined with dihydroartemisinin inhibits the excessive activation of skin keratinocytes in lupus erythematosus by targeting MAPK14.” Molecular and Cellular Probes.
@article{article5417,
title = {Prednisone combined with dihydroartemisinin inhibits the excessive activation of skin keratinocytes in lupus erythematosus by targeting MAPK14},
journal = {Molecular and Cellular Probes},
url = {https://www.sciencedirect.com/science/article/pii/S089085082600023X?dgcid=rss_sd_all}
}